Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
Clinical trial NCT01596751 · COMPLETED
Trial details
- NCT number
- NCT01596751
- Sponsor
- Hope Rugo, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-12
- Primary completion
- 2017-07-05
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.